Browse 24920 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
| Close Date | Grant Title | Agency |
| January 7th, 2025 |
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
| January 7th, 2025 |
Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| February 23rd, 2022 |
Discovery of the Genetic Basis of Childhood Cancers and of Structural Birth Defects: Gabriella Miller Kids First Pediatric Research Program (X01 Clinical Trial Not Allowed) |
National Institutes of Health |
| December 17th, 2021 |
Health Systems for Quality Health Services:Activity 5 - USAID Human Resources for Health (HRH), Quality Management and Community Health Systems |
Kenya USAID Nairobi |
| December 3rd, 2021 |
Community Led Monitoring-Routine Data Collection and Provider feedback |
US Mission to Kenya |
| February 3rd, 2022 |
FY 2022 AmeriCorps Seniors - American Rescue Plan Senior Demonstration Program |
AmeriCorps |
| March 30th, 2022 |
Home and Community-Based Physical Activity Interventions to Improve the Health of Wheelchair Users (R01 Clinical Trial Required) |
National Institutes of Health |
| December 15th, 2021 |
HEAL Initiative: Pragmatic and Implementation Studies for the Management of Sickle Cell Disease Pain (UG3/UH3, Clinical Trials Optional) |
National Institutes of Health |
| November 5th, 2024 |
Clinical Trial Readiness for Functional Neurological Disorders (U01 Clinical Trial Optional) |
National Institutes of Health |
| December 17th, 2021 |
Health Systems Leadership: Activity 1 - Health Sector Governance and Strategic Partnerships |
Kenya USAID Nairobi |
| December 17th, 2021 |
Health Sector Financing: Activity 2 - Health Financing Analytics and Social Protection Systems for Health and Activity 3 - Private Sector Engagement. |
Kenya USAID Nairobi |
| December 3rd, 2021 |
Community Led Monitoring-Routine Data Collection and Provider feedback |
US Mission to Kenya |
| December 15th, 2021 |
HEAL Initiative: Sickle Cell Disease Pain Management Trials Utilizing the Pain Management Effectiveness Research Network Cooperative Agreement (UG3/UH3, Clinical Trial Required) |
National Institutes of Health |
| January 18th, 2022 |
Cellular Senescence Network: Technology Development and Application in Human Systems (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 3rd, 2022 |
Cell-Specific Impact of Liquid-Liquid Phase Separation in Aging and AD/ADRD (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 31st, 2022 |
Physiologically Based Pharmacokinetic Model for Nose-to-Brain Drug Delivery (U01) Clinical Trial Optional |
Food and Drug Administration |
| January 19th, 2022 |
Cellular Senescence Network: Murine Tissue Mapping Centers (U54 - Clinical Trial Not Allowed) |
National Institutes of Health |
| November 30th, 2021 |
Potential New Care and Treatment (C&T) Health Activity. |
Dominican Republic USAID Santo Domingo |
| January 19th, 2022 |
Cellular Senescence Network: Technology Development and Application in Murine Systems (UG3/UH3 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 8th, 2022 |
Using Data Linkage to Understand Suicide Attempts, Self-Harm and Unintentional Drowning Deaths (U01) |
Centers for Disease Control and Prevention ERA |
|
| March 1st, 2022 |
Research Grants to Evaluate the Effectiveness of Physical Therapy-based Exercises and Movements Used to Reduce Older Adults Falls (U01) |
Centers for Disease Control and Prevention ERA |
| March 14th, 2022 |
Rigorous Evaluation of Strategies to Prevent Overdose through Linking People with Illicit Substance Use Disorders to Recovery Support Services |
Centers for Disease Control and Prevention ERA |
| December 15th, 2021 |
Limited Competition: NIH Health Care Systems Research Collaboratory - Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 30th, 2022 |
Elucidating the Role of Nutrition in Care and Development of Preterm Infants (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 30th, 2022 |
Promoting Reproductive Health for Adolescents and Adults with Disabilities (R01 Clinical Trial Optional) |
National Institutes of Health |
| December 28th, 2021 |
Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) |
National Institutes of Health |
| March 3rd, 2022 |
Understanding the Role of Bilingualism in Cognitive Reserve/Resilience in Aging and AD/ADRD (R01 Clinical Trial Optional) |
National Institutes of Health |
| March 7th, 2022 |
Development of advanced analytical methods for the characterization of complex generics |
Food and Drug Administration |
| March 31st, 2022 |
PBPK modeling to support assessment of bioequivalence of locally acting drugs in the gastrointestinal tract |
Food and Drug Administration |
| March 31st, 2022 |
Investigating the in vivo behavior and in vitro characteristics purportedly gastro-retentive extended release formulation to enhance the regulatory standard of such products |
Food and Drug Administration |
| March 31st, 2022 |
In Vitro Based Approaches to Evaluate the Bioequivalence of Generic Rectal and Vaginal Products |
Food and Drug Administration |
| March 31st, 2022 |
Cutaneous pharamcokinetic-based approaches to establish bioequivalence of topically applied drug products |
Food and Drug Administration |
| December 28th, 2021 |
Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) |
National Institutes of Health |
| December 28th, 2021 |
Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required) |
National Institutes of Health |
| February 24th, 2022 |
Understanding Polydrug Use Risk and Protective Factors, Patterns, and Trajectories to Prevent Drug Overdose |
Centers for Disease Control and Prevention ERA |
| December 10th, 2021 |
A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional) |
National Institutes of Health |
| September 13th, 2024 |
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
| March 8th, 2022 |
Tracking the burden, distribution, and impact of Post COVID-19 conditions in diverse populations for children, adolescents, and adults (Track PCC) |
Centers for Disease Control NCIRD |
| February 22nd, 2022 |
Rigorous Evaluation of Community-Level Substance Use and Overdose Prevention Frameworks that Incorporate ACEs-Related Prevention Strategies |
Centers for Disease Control and Prevention ERA |
| January 25th, 2022 |
Delta Region Rural Health Workforce Training Program |
Health Resources and Services Administration |
